drugset / Trial / NCT00967850
Efficacy and Safety of Intravitreal Bevacizumab in the Treatment of Choroidal Neovascular Membranes Associated to High Myopia
Phase 3
Completed
56 enrolled
Institute of Applied Ophthalmobiology - IOBA
Fondo de Investigacion Sanitaria · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of this study is to determine the efficacy and safety of intravitreal injections of bevacizumab in High Myopia´s choroidal neovascularization versus the standard treatment of Photodynamic therapy.
Timeline
- Start
- 2008-04
- Primary completion
- 2011-06
- Completion
- 2011-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bevacizumab | Monoclonal antibody | 1.25 mg | Intravitreal |
| Comparator | Verteporfin | Other / unclassified | — | — |